Nitinotes develops effective and safe minimally invasive solutions for treating obesity
2018
Year invested
Fund I
MTIP Fund
Israel
Location
Active Investment
Investment status
Obesity / Gastroenterology
Segment
Nitinotes is engaged in the fight against obesity, one of the fastest-growing conditions in the world. According to the World Health Organization, >1 billion people around the globe suffer from obesity, a largely untreated condition with <1% eligible to Standard of Care and a leading factor for early death. Nitinotes has developed EndoZip, a fully automated and minimally invasive medical device, allowing durable sutures to reduce the stomach size in obese patients for effective weight loss.
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.